Peer Review reports
From: Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
Original Submission | ||
---|---|---|
18 Jul 2017 | Submitted | Original manuscript |
3 Sep 2017 | Reviewed | Reviewer Report - Gwo Fuang Ho |
16 Oct 2017 | Reviewed | Reviewer Report - Hany Omar |
29 Oct 2017 | Reviewed | Reviewer Report - Sung Hwan Ki |
12 Mar 2018 | Author responded | Author comments - Yuko Murakami |
Resubmission - Version 2 | ||
12 Mar 2018 | Submitted | Manuscript version 2 |
17 Mar 2018 | Reviewed | Reviewer Report - Hany Omar |
24 Mar 2018 | Reviewed | Reviewer Report - Sung Hwan Ki |
25 Mar 2018 | Reviewed | Reviewer Report - Gwo Fuang Ho |
25 Apr 2018 | Author responded | Author comments - Yuko Murakami |
Resubmission - Version 3 | ||
25 Apr 2018 | Submitted | Manuscript version 3 |
2 May 2018 | Reviewed | Reviewer Report - Hany Omar |
30 May 2018 | Author responded | Author comments - Yuko Murakami |
Resubmission - Version 4 | ||
30 May 2018 | Submitted | Manuscript version 4 |
3 Jun 2018 | Author responded | Author comments - Yuko Murakami |
Resubmission - Version 5 | ||
3 Jun 2018 | Submitted | Manuscript version 5 |
10 Jun 2018 | Author responded | Author comments - Yuko Murakami |
Resubmission - Version 6 | ||
10 Jun 2018 | Submitted | Manuscript version 6 |
Publishing | ||
13 Jun 2018 | Editorially accepted | |
25 Jun 2018 | Article published | 10.1186/s12885-018-4588-y |
You can find further information about peer review here.